SSRIs, SNRIs exposure in utero predisposes children to developmental vulnerability
Children of mothers with a mood or anxiety disorder who used selective serotonin reuptake inhibitor (SSRI) or selective serotonin norepinephrine inhibitor (SNRI) during pregnancy are at high risk of developmental vulnerability as well as of language and cognitive difficulties, a study reports.
SSRIs, SNRIs exposure in utero predisposes children to developmental vulnerability
21 May 2020
